Dmitry Balyasny’s Medtronic MDT Stock Holding History

Dmitry Balyasny’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$571K	Sell	7,300 -1,100	-13%	-$88.7K	﹤0.01%	2461
2026 Q1	$728K	Sell	8,400 -10,900	-56%	-$1.04M	﹤0.01%	2208
2025 Q4	$1.85M	Sell	19,300 -218,800	-92%	-$21.3M	﹤0.01%	1903
2025 Q3	$22.7M	Buy	238,100 +208,200	+696%	+$19.1M	0.03%	662
2025 Q2	$2.61M	Sell	29,900 -39,200	-57%	-$3.32M	﹤0.01%	1594
2025 Q1	$6.21M	Sell	69,100 -9,000	-12%	-$805K	0.01%	1148
2024 Q4	$6.24M	Buy	78,100 +24,300	+45%	+$2.1M	0.01%	1175
2024 Q3	$4.84M	Buy	+53,800	New	+$4.53M	0.01%	1258
2024 Q2	–	Sell	-87,900	Closed	-$7.66M	–	2899
2024 Q1	$7.66M	Buy	87,900 +81,500	+1,273%	+$6.96M	0.01%	1051
2023 Q4	$527K	Buy	+6,400	New	+$488K	﹤0.01%	1936
2021 Q3	–	Sell	-6,200	Closed	-$770K	–	2234
2021 Q2	$770K	Buy	+6,200	New	+$778K	﹤0.01%	1402
2021 Q1	–	Sell	-50,000	Closed	-$5.86M	–	1956
2020 Q4	$5.86M	Sell	50,000 -100,000	-67%	-$11M	0.03%	592
2020 Q3	$15.6M	Buy	+150,000	New	+$15.1M	0.11%	261
2018 Q2	–	Sell	-350,000	Closed	-$28.1M	–	2003
2018 Q1	$28.1M	Buy	350,000 +30,000	+9%	+$2.47M	0.12%	242
2017 Q4	$25.8M	Buy	+320,000	New	+$25.6M	0.08%	327

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dmitry Balyasny's MDT Position: Q2 2026 in Review

Dmitry Balyasny increased its Medtronic (MDT) stake by 2,346% in Q2 2026, buying an estimated $76.3M and bringing the position to 986,367 shares worth $77.2M. The position accounts for 0.1% of the portfolio, ranked #246.

Dmitry Balyasny first reported a position in MDT in Q2 2013 and has held it in 40 quarters since. The position peaked at $220M in Q2 2025. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Dmitry Balyasny held 986,367 shares of Medtronic worth $77.2M as of Q2 2026.
Dmitry Balyasny bought 946,039 Medtronic shares in Q2 2026, an estimated $76.3M.
Medtronic made up 0.1% of Dmitry Balyasny's portfolio in Q2 2026, its #246 holding.
Dmitry Balyasny first reported a position in Medtronic in Q2 2013 and has held it in 40 quarters since.
Dmitry Balyasny's Medtronic position peaked at $220M in Q2 2025.
2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.